The global amino acids market enters the final stretch of 2024 characterised by widespread price stability though underlying tones vary by product and region. With Q4 mostly contracted and early Q1 discussions underway, trading activity is generally muted. Low prices, ample supply, and shifting cost drivers continue to shape buyer strategies heading into 2025. Highlights: Lysine: Prices remain stable with a slightly weak tone, and no major further decline is expected. Q1 is mostly contract
Get full access to all stories on All About Feed
This Premium article is exclusively available for subscribers.
Obtain insights from exclusive interviews
Dive into articles covering trending industry topics
Stay up-to-date on the market trends
All the news is brought to you by experienced editors and experts from around the world